Medline

Medline Forward P/E

The Forward P/E Ratio of Medline (MDLN) as of Oct 20, 2026 is 50.50. In the previous year, Forward P/E Ratio was 48.77 — a change of 3.54% (higher).

Forward P/E

50.50

YoY

3.54%

Last updated:

Forward P/E Ratio of Medline is 2025 50.50 . Forward P/E Ratio of Medline was 2024 48.77 . It decreases by 3.54% higher compared to the previous year.

The Medline Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2022
-2,341.04 USD
Jan 1, 2023
250.11 USD
Jan 1, 2024
48.77 USD
Jan 1, 2025
50.50 USD
The Medline Forward P/E history
YEARForward P/EYoY
50.50+3.54%
48.77-80.50%
250.11-110.68%
-2,341.04—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medline Stock analysis

What does Medline do? Medline Inc generates revenue through its Medline Brand and Supply Chain Solutions segments. The Medline Brand offers approximately 335,000 medical-surgical products organized into Front Line Care, Surgical Solutions, and Laboratory and Diagnostics categories, serving hospitals, surgery centers, physician offices, and post-acute facilities. Supply Chain Solutions procures and distributes third-party products from national brands while providing tailored logistics and supply chain optimization services to domestic and international customers. The company's mission-critical products include surgical and procedural kits, gloves, protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. Medline Brand products target healthcare facilities requiring daily mission-critical supplies, with Front Line Care focusing on immediate patient care needs, Surgical Solutions supporting operating rooms, and Laboratory and Diagnostics serving clinical testing environments. Supply Chain Solutions serves as a distribution partner for national brands, offering logistics expertise to optimize supply chains for healthcare providers across various care settings. The company's product portfolio supports all points of care, from acute to post-acute facilities, ensuring consistent product availability for daily operations. Customers purchasing Medline Brand products include hospitals, surgery centers, physician offices, and post-acute facilities, while Supply Chain Solutions serves domestic and international clients needing third-party product distribution and supply chain services. The firm's offerings cover the full range of care settings, with Surgical Solutions specifically targeting operating room environments and Laboratory and Diagnostics supporting clinical laboratories. Medline's product range ensures healthcare providers have access to essential supplies without disruption in daily operations. Medline is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medline stock

Forward P/E Ratio of Medline is 50.50 in 2025.

Forward P/E Ratio of Medline changed from 48.77 to 50.50, representing a 3.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Medline since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Medline with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Medline

All Key Metrics — Medline